RMD open

Keyphrases

Publications

volume 10, number 3, 2024

Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
George Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, Miguel Angel González-Gay, Alfonso Corrales, Solbritt Rantapää Dahlqvist, Petros P Sfikakis, Patrick Dessein, Linda Tsang, Carol Hitchon, Hani El-Gabalawy, Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Iris Jazmin Colunga-Pedraza, Dionicio Ángel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Anne Grete Semb, Durga Prasanna Misra, Ellen-Margrethe Hauge, George Kitas
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD open 10 (3) (2024)
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Karel Pavelka, Catalin Codreanu, Adrian Ciurea, Bente Glintborg, Maria Jose Santos, Ismail Sari, Žiga Rotar, Bjorn Gudbjornsson, Gary John Macfarlane, Heikki Relas, Florenzo Iannone, Karin Laas, Johan K Wallman, Marleen van de Sande, Sella Aarrestad Provan, Isabel Castrejon, Jakub Zavada, Corina Mogosan, Michael John Nissen, Anne Gitte Loft, Anabela Barcelos, Yesim Erez, Katja Perdan Pirkmajer, Gerdur Grondal, Gareth T Jones, Anna-Mari Hokkanen, Maria Sole Chimenti, Sigrid Vorobjov, Daniela Di Giuseppe, Tore K Kvien, Lucia Otero-Varela, Irene E van der Horst-Bruinsma, Merete Lund Hetland, Lykke Midtbøll Ørnbjerg
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study. RMD open 10 (3) (2024)
Özlem Satirer, Joerg Christoph Henes, Michaela Döring, Till Lesk, Susanne Benseler, Jasmin Beate Kuemmerle-Deschner
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD open 10 (3) (2024)
Roy M Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard G Combe, Stephen Hall, Nasser Khan, Kyle M Carter, Heidi S Camp, Andrea Rubbert-Roth
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD open 10 (3) (2024)
Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Anne Constanze Regierer, David Kiefer, Georg Schett, Andreas Krause, Anja Weiß, Philipp Sewerin, Anja Strangfeld
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry. RMD open 10 (3) (2024)
Leti van Bodegom-Vos, Thea P M Vliet Vlieland
Bridging the gap: facilitating the use of rheumatology research results in clinical practice with hybrid implementation effectiveness studies. RMD open 10 (3) (2024)
Cecilia Barnini, Louise Oni, Andreas Kronbichler
Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Özlem Satirer, Joerg Christoph Henes, Michaela Döring, Till Lesk, Susanne Benseler, Jasmin Beate Kuemmerle-Deschner
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD open 10 (3) (2024)
Ronald F Van Vollenhoven, Stephen Hall, Alvin F Wells, Sebastian Meerwein, Yanna Song, Oishi Tanjinatus, Roy M Fleischmann
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Thomas Khoo, Meghna Jani, Hector Chinoy
Is there a role for novel supplements in the management of fatigue in rheumatic diseases? RMD open 10 (3) (2024)
Anne Constanze Regierer, David Kiefer, Georg Schett, Andreas Krause, Anja Weiß, Philipp Sewerin, Anja Strangfeld
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry. RMD open 10 (3) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
Anne Constanze Regierer, David Kiefer, Georg Schett, Andreas Krause, Anja Weiß, Philipp Sewerin, Anja Strangfeld
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry. RMD open 10 (3) (2024)
Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Sherif Ismail, Suzana Jordan, Norina Zampatti, Aurora Maria Tatu, Oliver Distler, Carmen-Marina Mihai
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis? RMD open 10 (3) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Josef S Smolen, Cédric Lukas, Louis Bessette, Pendleton Wickersham, Tommaso Panni, Rebecca Bolce, Soyi Liu-Leage, Boris Janos, Michael John Nissen, James Cheng-Chung Wei
Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis. RMD open 10 (3) (2024)
Josef S Smolen, Cédric Lukas, Louis Bessette, Pendleton Wickersham, Tommaso Panni, Rebecca Bolce, Soyi Liu-Leage, Boris Janos, Michael John Nissen, James Cheng-Chung Wei
Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis. RMD open 10 (3) (2024)
Leti van Bodegom-Vos, Thea P M Vliet Vlieland
Bridging the gap: facilitating the use of rheumatology research results in clinical practice with hybrid implementation effectiveness studies. RMD open 10 (3) (2024)
Cecilia Barnini, Louise Oni, Andreas Kronbichler
Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach. RMD open 10 (3) (2024)
Josef S Smolen, Cédric Lukas, Louis Bessette, Pendleton Wickersham, Tommaso Panni, Rebecca Bolce, Soyi Liu-Leage, Boris Janos, Michael John Nissen, James Cheng-Chung Wei
Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis. RMD open 10 (3) (2024)
Roy M Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard G Combe, Stephen Hall, Nasser Khan, Kyle M Carter, Heidi S Camp, Andrea Rubbert-Roth
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD open 10 (3) (2024)
Leti van Bodegom-Vos, Thea P M Vliet Vlieland
Bridging the gap: facilitating the use of rheumatology research results in clinical practice with hybrid implementation effectiveness studies. RMD open 10 (3) (2024)
Thomas Khoo, Meghna Jani, Hector Chinoy
Is there a role for novel supplements in the management of fatigue in rheumatic diseases? RMD open 10 (3) (2024)
Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Sherif Ismail, Suzana Jordan, Norina Zampatti, Aurora Maria Tatu, Oliver Distler, Carmen-Marina Mihai
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis? RMD open 10 (3) (2024)
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Karel Pavelka, Catalin Codreanu, Adrian Ciurea, Bente Glintborg, Maria Jose Santos, Ismail Sari, Žiga Rotar, Bjorn Gudbjornsson, Gary John Macfarlane, Heikki Relas, Florenzo Iannone, Karin Laas, Johan K Wallman, Marleen van de Sande, Sella Aarrestad Provan, Isabel Castrejon, Jakub Zavada, Corina Mogosan, Michael John Nissen, Anne Gitte Loft, Anabela Barcelos, Yesim Erez, Katja Perdan Pirkmajer, Gerdur Grondal, Gareth T Jones, Anna-Mari Hokkanen, Maria Sole Chimenti, Sigrid Vorobjov, Daniela Di Giuseppe, Tore K Kvien, Lucia Otero-Varela, Irene E van der Horst-Bruinsma, Merete Lund Hetland, Lykke Midtbøll Ørnbjerg
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Roy M Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard G Combe, Stephen Hall, Nasser Khan, Kyle M Carter, Heidi S Camp, Andrea Rubbert-Roth
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD open 10 (3) (2024)
Roy M Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard G Combe, Stephen Hall, Nasser Khan, Kyle M Carter, Heidi S Camp, Andrea Rubbert-Roth
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD open 10 (3) (2024)
Ronald F Van Vollenhoven, Stephen Hall, Alvin F Wells, Sebastian Meerwein, Yanna Song, Oishi Tanjinatus, Roy M Fleischmann
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND. RMD open 10 (3) (2024)
George Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, Miguel Angel González-Gay, Alfonso Corrales, Solbritt Rantapää Dahlqvist, Petros P Sfikakis, Patrick Dessein, Linda Tsang, Carol Hitchon, Hani El-Gabalawy, Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Iris Jazmin Colunga-Pedraza, Dionicio Ángel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Anne Grete Semb, Durga Prasanna Misra, Ellen-Margrethe Hauge, George Kitas
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD open 10 (3) (2024)
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Karel Pavelka, Catalin Codreanu, Adrian Ciurea, Bente Glintborg, Maria Jose Santos, Ismail Sari, Žiga Rotar, Bjorn Gudbjornsson, Gary John Macfarlane, Heikki Relas, Florenzo Iannone, Karin Laas, Johan K Wallman, Marleen van de Sande, Sella Aarrestad Provan, Isabel Castrejon, Jakub Zavada, Corina Mogosan, Michael John Nissen, Anne Gitte Loft, Anabela Barcelos, Yesim Erez, Katja Perdan Pirkmajer, Gerdur Grondal, Gareth T Jones, Anna-Mari Hokkanen, Maria Sole Chimenti, Sigrid Vorobjov, Daniela Di Giuseppe, Tore K Kvien, Lucia Otero-Varela, Irene E van der Horst-Bruinsma, Merete Lund Hetland, Lykke Midtbøll Ørnbjerg
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study. RMD open 10 (3) (2024)
George Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, Miguel Angel González-Gay, Alfonso Corrales, Solbritt Rantapää Dahlqvist, Petros P Sfikakis, Patrick Dessein, Linda Tsang, Carol Hitchon, Hani El-Gabalawy, Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Iris Jazmin Colunga-Pedraza, Dionicio Ángel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Anne Grete Semb, Durga Prasanna Misra, Ellen-Margrethe Hauge, George Kitas
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD open 10 (3) (2024)
Ronald F Van Vollenhoven, Stephen Hall, Alvin F Wells, Sebastian Meerwein, Yanna Song, Oishi Tanjinatus, Roy M Fleischmann
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND. RMD open 10 (3) (2024)
Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
Pascal Hendrik Pieter de Jong, Agnes E M Looijen, Annette H M van der Helm van Mil, Pascal Hendrik Pieter de Jong, Elise van Mulligen
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis? RMD open 10 (3) (2024)
Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Sherif Ismail, Suzana Jordan, Norina Zampatti, Aurora Maria Tatu, Oliver Distler, Carmen-Marina Mihai
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis? RMD open 10 (3) (2024)
Cecilia Barnini, Louise Oni, Andreas Kronbichler
Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach. RMD open 10 (3) (2024)
Özlem Satirer, Joerg Christoph Henes, Michaela Döring, Till Lesk, Susanne Benseler, Jasmin Beate Kuemmerle-Deschner
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Roy M Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, Bernard G Combe, Stephen Hall, Nasser Khan, Kyle M Carter, Heidi S Camp, Andrea Rubbert-Roth
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD open 10 (3) (2024)
Pascal Hendrik Pieter de Jong, Agnes E M Looijen, Annette H M van der Helm van Mil, Pascal Hendrik Pieter de Jong, Elise van Mulligen
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis? RMD open 10 (3) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Leti van Bodegom-Vos, Thea P M Vliet Vlieland
Bridging the gap: facilitating the use of rheumatology research results in clinical practice with hybrid implementation effectiveness studies. RMD open 10 (3) (2024)